Bemarituzumab Human Monoclonal Antibody
Bemarituzumabis a research-grade recombinant antibody targeting CD332. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
K-sam, KSAM, CD332, Keratinocyte growth factor receptor, Fibroblast growth factor receptor 2, FGFR-2, FGFR2, KGFR, BEK
UniProt
P21802
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fibronectin (HFN7.1), CF740 conjugate, 0.1mg/mL
MAGE A1 (MA454), CF640R conjugate, 0.1mg/mL
CD44 Standard (DF1485), CF680 conjugate, 0.1mg/mL
CD50 / ICAM3 (CG106), CF740 conjugate, 0.1mg/mL
CD50 / ICAM3 (CG106), CF568 conjugate, 0.1mg/mL
